Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance
Identifieur interne : 00CF78 ( Main/Exploration ); précédent : 00CF77; suivant : 00CF79Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance
Auteurs : P. Baille [France] ; R. Bruno [France] ; J. H. M. Schellens [Pays-Bas] ; L. K. Webster [Australie] ; M. Millward [Australie] ; J. Verweij [Pays-Bas] ; G. Montay [France]Source :
- Clinical cancer research [ 1078-0432 ] ; 1997.
Descripteurs français
- Pascal (Inist)
- Docétaxel, Anticancéreux, Cisplatine, Tumeur solide, Tumeur maligne, Homme, Essai clinique phase II, Estimation Bayes, Activité biologique, Pharmacocinétique, Elimination, Plasma sanguin, Voie intraveineuse, Association médicamenteuse, Chimiothérapie, Traitement, Platine II Complexe, Interaction médicamenteuse, Validation, Simulation.
- Wicri :
- topic : Homme, Simulation.
English descriptors
- KwdEn :
- Antineoplastic agent, Bayes estimation, Biological activity, Blood plasma, Chemotherapy, Cisplatin, Docetaxel, Drug combination, Drug interaction, Elimination, Human, Intravenous administration, Malignant tumor, Pharmacokinetics, Phase II trial, Platinum II Complexes, Simulation, Solid tumor, Treatment, Validation.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 006917
- to stream PascalFrancis, to step Curation: 006752
- to stream PascalFrancis, to step Checkpoint: 006665
- to stream Main, to step Merge: 00E101
- to stream Main, to step Curation: 00CF78
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance</title><author><name sortKey="Baille, P" sort="Baille, P" uniqKey="Baille P" first="P." last="Baille">P. Baille</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>92165 Antony</wicri:noRegion><wicri:noRegion>20 Avenue Raymond Aron</wicri:noRegion><wicri:noRegion>92165 Antony</wicri:noRegion></affiliation></author><author><name sortKey="Bruno, R" sort="Bruno, R" uniqKey="Bruno R" first="R." last="Bruno">R. Bruno</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>92165 Antony</wicri:noRegion><wicri:noRegion>20 Avenue Raymond Aron</wicri:noRegion><wicri:noRegion>92165 Antony</wicri:noRegion></affiliation></author><author><name sortKey="Schellens, J H M" sort="Schellens, J H M" uniqKey="Schellens J" first="J. H. M." last="Schellens">J. H. M. Schellens</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital</s1><s2>3075 EA Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>3075 EA Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Webster, L K" sort="Webster, L K" uniqKey="Webster L" first="L. K." last="Webster">L. K. Webster</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Experimental Chemotherapy and Pharmacology Laboratory, Peter MacCallum Cancer Institute</s1><s2>Melbourne 3000</s2><s3>AUS</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Millward, M" sort="Millward, M" uniqKey="Millward M" first="M." last="Millward">M. Millward</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Experimental Chemotherapy and Pharmacology Laboratory, Peter MacCallum Cancer Institute</s1><s2>Melbourne 3000</s2><s3>AUS</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Verweij, J" sort="Verweij, J" uniqKey="Verweij J" first="J." last="Verweij">J. Verweij</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital</s1><s2>3075 EA Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>3075 EA Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Montay, G" sort="Montay, G" uniqKey="Montay G" first="G." last="Montay">G. Montay</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>92165 Antony</wicri:noRegion><wicri:noRegion>20 Avenue Raymond Aron</wicri:noRegion><wicri:noRegion>92165 Antony</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">97-0487315</idno><date when="1997">1997</date><idno type="stanalyst">PASCAL 97-0487315 INIST</idno><idno type="RBID">Pascal:97-0487315</idno><idno type="wicri:Area/PascalFrancis/Corpus">006917</idno><idno type="wicri:Area/PascalFrancis/Curation">006752</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">006665</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">006665</idno><idno type="wicri:doubleKey">1078-0432:1997:Baille P:optimal:sampling:strategies</idno><idno type="wicri:Area/Main/Merge">00E101</idno><idno type="wicri:Area/Main/Curation">00CF78</idno><idno type="wicri:Area/Main/Exploration">00CF78</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance</title><author><name sortKey="Baille, P" sort="Baille, P" uniqKey="Baille P" first="P." last="Baille">P. Baille</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Antony</settlement></placeName></affiliation></author><author><name sortKey="Bruno, R" sort="Bruno, R" uniqKey="Bruno R" first="R." last="Bruno">R. Bruno</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Antony</settlement></placeName></affiliation></author><author><name sortKey="Schellens, J H M" sort="Schellens, J H M" uniqKey="Schellens J" first="J. H. M." last="Schellens">J. H. M. Schellens</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital</s1><s2>3075 EA Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>3075 EA Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Webster, L K" sort="Webster, L K" uniqKey="Webster L" first="L. K." last="Webster">L. K. Webster</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Experimental Chemotherapy and Pharmacology Laboratory, Peter MacCallum Cancer Institute</s1><s2>Melbourne 3000</s2><s3>AUS</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Millward, M" sort="Millward, M" uniqKey="Millward M" first="M." last="Millward">M. Millward</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Experimental Chemotherapy and Pharmacology Laboratory, Peter MacCallum Cancer Institute</s1><s2>Melbourne 3000</s2><s3>AUS</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Verweij, J" sort="Verweij, J" uniqKey="Verweij J" first="J." last="Verweij">J. Verweij</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital</s1><s2>3075 EA Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>Pays-Bas</country><wicri:noRegion>3075 EA Rotterdam</wicri:noRegion></affiliation></author><author><name sortKey="Montay, G" sort="Montay, G" uniqKey="Montay G" first="G." last="Montay">G. Montay</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Drug Metabolism and Pharmacokinetics, Box 58, Rhône Poulenc Rorer, 20 Avenue Raymond Aron</s1><s2>92165 Antony</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>92165 Antony</wicri:noRegion><wicri:noRegion>20 Avenue Raymond Aron</wicri:noRegion><wicri:noRegion>92165 Antony</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Clinical cancer research</title><title level="j" type="abbreviated">Clin. cancer res.</title><idno type="ISSN">1078-0432</idno><imprint><date when="1997">1997</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Clinical cancer research</title><title level="j" type="abbreviated">Clin. cancer res.</title><idno type="ISSN">1078-0432</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic agent</term><term>Bayes estimation</term><term>Biological activity</term><term>Blood plasma</term><term>Chemotherapy</term><term>Cisplatin</term><term>Docetaxel</term><term>Drug combination</term><term>Drug interaction</term><term>Elimination</term><term>Human</term><term>Intravenous administration</term><term>Malignant tumor</term><term>Pharmacokinetics</term><term>Phase II trial</term><term>Platinum II Complexes</term><term>Simulation</term><term>Solid tumor</term><term>Treatment</term><term>Validation</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Docétaxel</term><term>Anticancéreux</term><term>Cisplatine</term><term>Tumeur solide</term><term>Tumeur maligne</term><term>Homme</term><term>Essai clinique phase II</term><term>Estimation Bayes</term><term>Activité biologique</term><term>Pharmacocinétique</term><term>Elimination</term><term>Plasma sanguin</term><term>Voie intraveineuse</term><term>Association médicamenteuse</term><term>Chimiothérapie</term><term>Traitement</term><term>Platine II Complexe</term><term>Interaction médicamenteuse</term><term>Validation</term><term>Simulation</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Simulation</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Pays-Bas</li></country><region><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Antony</li><li>Melbourne</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Baille, P" sort="Baille, P" uniqKey="Baille P" first="P." last="Baille">P. Baille</name></region><name sortKey="Bruno, R" sort="Bruno, R" uniqKey="Bruno R" first="R." last="Bruno">R. Bruno</name><name sortKey="Montay, G" sort="Montay, G" uniqKey="Montay G" first="G." last="Montay">G. Montay</name></country><country name="Pays-Bas"><noRegion><name sortKey="Schellens, J H M" sort="Schellens, J H M" uniqKey="Schellens J" first="J. H. M." last="Schellens">J. H. M. Schellens</name></noRegion><name sortKey="Verweij, J" sort="Verweij, J" uniqKey="Verweij J" first="J." last="Verweij">J. Verweij</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Webster, L K" sort="Webster, L K" uniqKey="Webster L" first="L. K." last="Webster">L. K. Webster</name></region><name sortKey="Millward, M" sort="Millward, M" uniqKey="Millward M" first="M." last="Millward">M. Millward</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00CF78 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00CF78 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:97-0487315
|texte= Optimal sampling strategies for bayesian estimation of docetaxel (taxotere) clearance
}}
| This area was generated with Dilib version V0.6.33. |  |